Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast Cancer

Dr. Hope Rugo Examines Angiogenesis Inhibition for Advanced Breast CancerПодробнее

Dr. Rugo on Guidelines for the Treatment of Metastatic Breast CancerПодробнее

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer ManagementПодробнее

Hope Rugo, MD: Chemotherapy Agents and Breast Cancer TreatmentПодробнее

Dr. Rugo on Chemotherapy for Metastatic Breast CancerПодробнее

Dr. Hope Rugo | San Antonio Breast Cancer Symposium 2022 | General SessionПодробнее

Dr. Hope Rugo – ESMO 2022 – Exploring the latest trial data & advances in breast cancer treatmentsПодробнее

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Hope Rugo on the First-line Superiority of Paclitaxel for Advanced Breast CancerПодробнее

UCSF at #AACR24: Hope Rugo, MD | Clinical Trials Discussant on "Advanced in Targeted Therapy"Подробнее

Hope Rugo, MD, provides perspective on the clinical progress of CDK 4/6 inhibitors in breast cancerПодробнее

Hope Rugo, MD, considers the incidence of TNBC and what makes this disease so difficult to treatПодробнее

Breast Cancer | Hope S Rugo, MDПодробнее

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast CancerПодробнее

Dr. Rugo on Hormone Therapy for Patients With Breast CancerПодробнее

Dr. Rugo Discusses the Future of Angiogenesis in Breast CancerПодробнее

Hope Rugo, MD, offers key takeaways for physicians regarding KEYNOTE-355Подробнее

Dr. Rugo on Pathway Blockade in Breast CancerПодробнее

Dr. Rugo on the Future of Extended Adjuvant Hormone Therapy for Breast CancerПодробнее